Inhibita 20 mg
Omeprazole
Category: Capsule
Manufacturer: Delta Pharma Ltd.
Price: 400.0 ৳
100's pack
piece
Medicine Selling service is not available yet.
Related Medicines
Inhibita is indicated for the treatment of-
Duodenal and gastric ulcer.
Gastric and duodenal ulcers brought on by NSAIDs.
In individuals who have a history of duodenal and stomach ulcers brought on by NSAIDs, as a preventative treatment.
The disease of gastroesophageal reflux.
care of acid reflux illness throughout the long term.
dyspepsia brought on by acid.
severe reflux esophagitis with ulcers.
prevention of aspiration of acid while under general anesthesia.
syndrome of Zollinger-Ellison.
Peptic ulcer brought on by Helicobacter pylori.
Proton Pump Blocker
An inhibitor of stomach acid secretion is omeprazole, a benzimidazole replacement. By inhibiting the hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell, it prevents the release of gastric acid. Following oral administration, the antisecretory effect starts to take effect in about an hour, peaks in two hours, and the inhibition of secretion lasts up to 72 hours. Secretory activity gradually resumes when the medicine is stopped, over a period of 3 to 5 days.
Warfarin, phenytoin, and diazepam might all take longer to leave the body when taken with omeprazole. Due to this, when Omeprazole is added to the treatment, a reduction in the dose of warfarin or phenytoin may be required. Theophylline, propranolol, or antacids have not been shown to interact with omeprazole.
Those who have a history of recognized hypersensitivity to any of the formulation's ingredients should not take omeprazole.
Most people tolerate omeprazole well. It has been reported that mild and temporary side effects such as nausea, stomach cramping, paresthesia, dizziness, and headache rarely require dosage adjustments.
Omeprazole is within the C pregnancy category according to the US FDA. Three prospective epidemiological studies' findings, however, show that omeprazole has no negative impact on pregnancy or the health of the fetus or baby. Omeprazole's entry into breast milk and its effects on the developing baby are not known. So, if Omeprazole use is deemed necessary, breastfeeding should be stopped.
Before starting therapy with Omeprazole for a suspected stomach ulcer, it is important to rule out the possibility of gastric cancer because the medication may make the symptoms worse and postpone a diagnosis.
Keep dry and away from heat and light. Keep out of children's reach.
Proton Pump Blocker
A benzimidazole replacement called omeprazole inhibits the production of stomach acid. By inhibiting the hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell, it prevents the release of gastric acid. Upon oral administration, the antisecretory effect begins to take effect within an hour, reaches its peak within two hours, and the inhibition of secretion lasts up to 72 hours. After the medicine is stopped, secretory activity gradually resumes over a period of 3 to 5 days.
Omeprazole is within the C pregnancy category according to the US FDA. Three prospective epidemiological studies' findings, however, show that omeprazole has no negative impact on pregnancy or the health of the fetus or baby. Omeprazole's entry into breast milk and its effects on the developing baby are not known. So, if Omeprazole use is deemed necessary, breastfeeding should be stopped.
Samm Care